New booster shots cut risk of symptomatic COVID-19 : vimarsa

The new bivalent COVID-19 booster shots are up to 56% more effective at preventing symptomatic COVID-19 infection than the two original COVID-19 vaccines in adults ages 18 and up, according to new data from the Centers for Disease Control and Prevention. The data, released Tuesday, is the first batch of effectiveness data from an official, large-scale study on the updated shots, ...

Related Keywords

United States , Washington , White House , District Of Columbia , Americans , Anthony Fauci , Centers For Disease , National Institute Of Allergy , National Institutes Of Health , Disease Control , National Institute , Infectious Diseases Anthony Fauci , National Institutes , House Republicans , Health And Wellness , Medicinal Drugs , Health Sciences , Public Health , Treatments And Therapies , Vaccines And Immunizations , Politics And Government , Government Agencies Us , Centers For Disease Control And Prevention , Executive Branch , Department Of Health And Human Services , North America , Americas ,